FrancophonIA/ELRC3.0 huggingface dataset:
English: This means that Olanzapine Cipla is similar to a ‘reference medicine' already authorised in the European Union (EU) called Zyprexa.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Zyprexa.
English: What are the benefits and risks of Olanzapine Cipla?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Olanzapine Cipla?
English: This is a summary of the European public assessment report (EPAR) for Olanzapine Cipla.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Olanzapine Cipla.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Olanzapine Cipla.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Olanzapine Cipla, na podlagi česar je oblikoval mnenje za odobritev dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: The CHMP concluded that, in accordance with EU requirements, Olanzapine Cipla has been shown to have comparable quality and to be bioequivalent to Zyprexa.
Slovenian: CHMP je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Olanzapine Cipla primerljivo raven kakovosti kot zdravilo Zyprexa ter da mu je biološko enakovredno.
English: Olanzapine Cipla is also used to treat moderate to severe manic episodes (extremely high mood) in adults.
Slovenian: Zdravilo Olanzapine Cipla se uporablja tudi za zdravljenje zmernih do hudih maničnih epizod (izjemno privzdignjenega razpoloženja) pri odraslih.
English: Because Olanzapine Cipla is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine's.
Slovenian: Ker je zdravilo Olanzapine Cipla generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
English: Olanzapine Cipla 1
Slovenian: Olanzapine Cipla olanzapin
English: Because Olanzapine Cipla is a generic medicine, studies in patients have been limited to tests to demonstrate that it is bioequivalent to the reference medicine, Zyprexa.
Slovenian: Ker je zdravilo Olanzapine Cipla generično zdravilo, so bile študije omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Zyprexa.
English: Therefore, the CHMP's view was that, as for Zyprexa, the benefit outweighs the identified risk.
Slovenian: Zato je menil, da koristi, tako kot pri zdravilu Zyprexa, odtehtajo znana tveganja.
English: Olanzapine Cipla is a medicine that contains the active substance olanzapine.
Slovenian: Olanzapine Cipla je zdravilo, ki vsebuje zdravilno učinkovino olanzapin.
English: Why has Olanzapine Cipla been approved?
Slovenian: Zakaj je bilo zdravilo Olanzapine Cipla odobreno?
English: Olanzapine Cipla is used to treat adults with schizophrenia.
Slovenian: Zdravilo Olanzapine Cipla se uporablja za zdravljenje shizofrenije.
English: The active substance in Olanzapine Cipla, olanzapine, is an antipsychotic medicine.
Slovenian: Zdravilna učinkovina zdravila Olanzapine Cipla je olanzapin, ki je antipsihotično zdravilo.
English: Other information about Olanzapine Cipla
Slovenian: Druge informacije o zdravilu Olanzapine Cipla
English: The Committee recommended that Olanzapine Cipla be given marketing authorisation.
Slovenian: Priporočil je, da se za zdravilo Olanzapine Cipla odobri dovoljenje za promet.
English: What is Olanzapine Cipla used for?
Slovenian: Za kaj se zdravilo Olanzapine Cipla uporablja?
English: What is Olanzapine Cipla?
Slovenian: Kaj je zdravilo Olanzapine Cipla?
English: How has Olanzapine Cipla been studied?
Slovenian: Kako je bilo zdravilo Olanzapine Cipla raziskano?
English: How is Olanzapine Cipla used?
Slovenian: Kako se zdravilo Olanzapine Cipla uporablja?
English: How does Olanzapine Cipla work?
Slovenian: Kako zdravilo Olanzapine Cipla deluje?
English: Among these, dyskinesia (difficulty controlling movement) may affect around 2 in 10 people.
Slovenian: Od teh lahko diskinezija (težave z nadzorovanjem gibanja) prizadene približno 2 osebi od 10.
English: What measures are being taken to ensure the safe and effective use of Ongentys?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Ongentys?
English: Ongentys must not be used in:
Slovenian: Zdravilo Ongentys se ne sme uporabljati pri:
English: The full EPAR for Ongentys can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Ongentys je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Ongentys's benefits are greater than its risks and recommended that it be approved for use in the EU.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Ongentys večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
English: Fluctuations happen when the effects of the medication wear off and symptoms re-emerge before the next dose is due.
Slovenian: Nihanja se pojavijo, ko učinki zdravila pojenjajo in se simptomi ponovno pojavijo še pred naslednjim odmerkom.
English: This is a summary of the European public assessment report (EPAR) for Ongentys.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Ongentys.
English: It is not intended to provide practical advice on how to use Ongentys.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ongentys have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo zdravstveni delavci in bolniki upoštevati za varno in učinkovito uporabo zdravila Ongentys, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: Ongentys opicapone
Slovenian: Ongentys opikapon
English: In both studies, patients had on average off periods of about 6 to 7 hours at the start of the study.
Slovenian: V obeh študijah je čas izklopa pri bolnikih ob začetku študije povprečno znašal od 6 do 7 ur.
English: The benefits of Ongentys in Parkinson's disease were investigated in two main studies.
Slovenian: Koristi zdravila Ongentys pri Parkinsonovi bolezni so proučevali v dveh glavnih študijah.
English: Regarding its safety, Ongentys was considered to be comparable to other medicines of the same class.
Slovenian: Z vidika varnosti je bilo zdravilo Ongentys ocenjeno kot primerljivo z drugimi zdravili istega razreda.
English: Both studies were extended for one additional year and confirmed the benefits of Ongentys when used long-term.
Slovenian: Obe študiji so podaljšali za eno leto, s čimer so potrdili koristi dolgotrajne uporabe zdravila Ongentys.
English: Opicapone blocks an enzyme that is involved in the breakdown of levodopa in the body called catechol-O-methyl transferase (COMT).
Slovenian: Opikapon blokira encim, ki sodeluje pri razgradnji levodope v telesu, imenovan katehol-O-metiltransferaza (COMT).
English: This study looked at how well the treatments reduced the time when patients have more difficulty moving about, called ‘off periods'.
Slovenian: V tej študiji so proučevali, kako učinkovito so zdravila skrajšala čas, ko so imeli bolniki več težav z gibanjem - „čas izklopa“.
English: Ongentys is available as capsules (25 mg and 50 mg) to be taken by mouth.
Slovenian: Zdravilo Ongentys je na voljo v obliki kapsul (25 mg in 50 mg), ki se jemljejo peroralno.
English: Ongentys is used when these fluctuations cannot be treated with the standard levodopa-containing combinations alone.
Slovenian: Zdravilo Ongentys se uporablja, kadar teh nihanj ni možno zdraviti samo s standardnimi kombinacijami, ki vsebujejo levodopo.
English: Other information about Ongentys
Slovenian: Druge informacije o zdravilu Ongentys
English: They are linked to a reduction in the effect of levodopa, when the patient experiences sudden switches between being ‘on' and able to move, and being ‘off' and having difficulty moving about.
Slovenian: Povezana so z zmanjšanim učinkom levodope, ko bolnik doživlja nenadne preskoke med stanjem„vklopa“, ko se lahko giba, in stanjem „izklopa“, ko ima težave z gibanjem.
English: The patients then lose their ability to control their movements reliably.
Slovenian: Bolniki nato izgubijo zmožnost zanesljivega nadzorovanja gibov.
English: The recommended dose is 50 mg, taken once a day at bedtime, at least one hour before or after levodopa combination medicines.
Slovenian: Priporočeni odmerek je 50 mg enkrat na dan pred spanjem vsaj eno uro pred zdravilom s kombinacijo levodope ali po njem.
English: • patients taking medicines known as non-selective monoamine oxidase (MAO) inhibitors except when used to treat Parkinson's disease.
Slovenian: • bolnikih, ki prejemajo zdravila, znana kot neselektivni zaviralci monoaminoksidaze (MAO), razen pri uporabi za zdravljenje Parkinsonove bolezni.
English: For more information about treatment with Ongentys, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Ongentys preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: What is Ongentys and what is it used for?
Slovenian: Kaj je zdravilo Ongentys in za kaj se uporablja?
English: For practical information about using Ongentys, patients should read the package leaflet or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Ongentys naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
English: What are the risks associated with Ongentys?
Slovenian: Kakšna tveganja so povezana z zdravilom Ongentys?
English: It enhances the effects of levodopa, a copy of the neurotransmitter dopamine that can be taken by mouth.
Slovenian: Okrepi učinke levodope, kopije živčnega prenašalca dopamina, ki se lahko jemlje peroralno.
English: • patients with a history of neuroleptic malignant syndrome (a nervous system disorder usually caused by antipsychotic medicines) or rhabdomyolysis (breakdown of muscle fibres);
Slovenian: • bolnikih z anamnezo nevroleptičnega malignega sindroma (bolezni živčevja, ki jo običajno povzročijo antipsihotiki) ali rabdomiolize (razgradnje mišičnih vlaken);
English: Why is Ongentys approved?
Slovenian: Zakaj je bilo zdravilo Ongentys odobreno?
English: What benefits of Ongentys have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Ongentys izkazalo v študijah?
English: Ongentys is a medicine used to treat adults with Parkinson's disease, a progressive brain disorder that causes shaking and muscle stiffness, and slows movement.
Slovenian: Zdravilo Ongentys se uporablja za zdravljenje odraslih s Parkinsonovo boleznijo, tj. napredujočo okvaro možganov, ki povzroča tresenje in togost mišic ter upočasnjeno gibanje.
English: In the second study, which also looked at the reduction in off periods, Ongentys was compared with placebo in 427 patients who were taking a levodopa / DDCI combination.
Slovenian: V drugi študiji, v kateri so prav tako proučevali skrajšanje časa izklopa, so pri 427 bolnikih, ki so prejemali kombinacijo z levodopo/zaviralci DDK, zdravilo Ongentys primerjali s placebom.
English: The active substance in Ongentys, opicapone, works to restore the levels of dopamine in the parts of the brain that control movement and coordination.
Slovenian: Zdravilna učinkovina v zdravilu Ongentys, opikapon, deluje tako, da obnovi ravni dopamina v predelih možganov, ki nadzorujejo gibanje in koordinacijo gibov.
English: • patients with tumours of the adrenal glands (small glands located on top of the kidneys) such as pheochromocytoma and paraganglioma;
Slovenian: • bolnikih s tumorjem nadledvičnih žlez (majhnih žlez na vrhu ledvic), kot sta feokromocitom in paragangliom;
English: For the full list of all side effects reported with Ongentys, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Ongentys, glejte navodilo za uporabo.
English: The most common side effects with Ongentys are disorders of the nervous system (brain and spinal cord).
Slovenian: Najpogostejši neželeni učinki zdravila Ongentys so bolezni živčevja (možganov in hrbtenjače).
English: Ongentys contains the active substance opicapone.
Slovenian: Zdravilo Ongentys vsebuje zdravilno učinkovino opikapon.
English: After 14-15 weeks, off periods were shortened by 117 minutes (almost 2 hours) in patients taking Ongentys 50 mg, compared with 96 minutes (about 1 and a half hour) in patients taking the comparator medicine entacapone and 56 minutes (less than 1 hour) in patients taking placebo.
Slovenian: Po preteku 14 do 15 tednov se je čas izklopa pri bolnikih, ki so prejemali zdravilo Ongentys 50 mg, skrajšal za 117 minut (skoraj dve uri), pri bolnikih, ki so prejemali primerjalno zdravilo entakapon, za 96 minut (okrog eno uro in pol), pri bolnikih, ki so prejemali placebo, pa za 56 minut (manj kot eno uro).
English: Ongentys is used as an add-on to levodopa / DOPA decarboxylase inhibitors (DDCI) (other medicines for Parkinson's disease) in patients who are having fluctuations in the control of their condition.
Slovenian: Zdravilo Ongentys se uporablja kot dodatno zdravljenje k zdravilom z levodopo/zaviralci dopa dekarboksilaze (DDK) (drugim zdravilom proti Parkinsonovi bolezni) pri bolnikih z nihanji pri nadzoru bolezni.
English: After 14-15 weeks, off periods were shortened by 119 minutes (almost 2 hours) in patients taking Ongentys 50 mg, compared with 64 minutes in patients taking placebo.
Slovenian: Po preteku 14 do 15 tednov se je čas izklopa pri bolnikih, ki so prejemali zdravilo Ongentys 50 mg, skrajšal za 119 minut (skoraj dve uri), pri bolnikih, ki so prejemali placebo, pa za 64 minut.
English: In the first study, 600 patients with fluctuations were given Ongentys, entacapone (another medicine for Parkinson's disease) or placebo (a dummy treatment), in addition to their current levodopa / DDCI combination.
Slovenian: V prvi študiji je 600 bolnikov z nihanji poleg kombinacije z levodopo/zaviralci DDK, ki so jo že prejemali, prejemalo zdravilo Ongentys, entakapon (drugo zdravilo proti Parkinsonovi bolezni) ali placebo (zdravilo brez zdravilne učinkovine).
English: How is Ongentys used?
Slovenian: Kako se zdravilo Ongentys uporablja?
English: Ongentys was shown to be more effective than placebo and at least as effective as the comparator entacapone in reducing off periods in patients with Parkinson's disease taking levodopa combination medicines.
Slovenian: Zdravilo Ongentys se je pri skrajševanju časa izklopa pri bolnikih s Parkinsonovo boleznijo, ki so jemali zdravila z levodopo, pokazalo kot učinkovitejše od placeba in vsaj tako učinkovito kot primerjalno zdravilo entakapon.
English: How does Ongentys work?
Slovenian: Kako zdravilo Ongentys deluje?
English: This helps to improve the symptoms of Parkinson's disease, such as stiffness and slowness of movement.
Slovenian: Tako ostane levodopa aktivna dlje, kar pomaga izboljšati simptome Parkinsonove bolezni, kot je togost in upočasnjeno gibanje.
English: 036 80 Martin Slovak Republic
Slovenian: 036 80 Martin Slovaška republika
English: The recommended dose is
Slovenian: Priporočeni odmerek je
English: The safety and efficacy of sildenafil was maintained in long-term studies.
Slovenian: Varnost in učinkovitost sildenafila sta se ohranili tudi v dolgoročnih študijah.
English: It is not possible to determine whether these events are related directly to these factors or to other factors.
Slovenian: Ali so ti dogodki neposredno povezani s temi dejavniki ali pa z drugimi dejavniki, ni mogoče ugotoviti.
English: There are no adequate and well-controlled studies in pregnant or breast-feeding women.
Slovenian: Ni zadostnih in dobro nadzorovanih študij pri nosečnicah in doječih ženskah.
English: Please tell your doctor about this.
Slovenian: O tem obvestite zdravnika.
English: ● Risk Management Plan (RMP) Not applicable.
Slovenian: • Načrt za obvladovanje tveganja (RMP) Navedba smiselno ni potrebna.
English: Most, but not all, of these patients had pre-existing cardiovascular risk factors.
Slovenian: Večina teh bolnikov, ne pa vsi, je imela že prej obstoječe kardiovaskularne dejavnike tveganja.
English: However, due to high inter-subject variability, these differences were not statistically significant.
Slovenian: Vendar te razlike zaradi velike variabilnosti med posamezniki niso bile statistično značilne.
English: Alcoholic drink can make erection difficulties worse.
Slovenian: Alkoholne pijače lahko poslabšajo težave z erekcijo.
English: Tell your doctor if you are taking any of these medicines.
Slovenian: Obvestite zdravnika, če jemljete katero od teh zdravil.
English: Stevens-Johnson Syndrome (SJS)*, Toxic Epidermal Necrolysis (TEN)*
Slovenian: Stevens-Johnsonov sindrom (SJS),* toksična epidermalna nekroliza (TEN)*
English: Date of latest renewal: 9 September 2014.
Slovenian: Datum prve odobritve: 23. december 2009 Datum zadnjega podaljšanja: 9. september 2014
English: Elderly Dosage adjustments are not required in elderly patients (≥ 65 years old).
Slovenian: Starejši bolniki Pri starejših bolnikih odmerka ni potrebno prilagajati (≥ 65 let).
English: Posology Use in adults
Slovenian: Uporaba pri odraslih
English: Children and adolescents This medicine should NOT be given to children and adolescents under the age of 18.
Slovenian: Otroci in mladostniki Otroci in mladostniki do 18. leta starosti NE smejo dobiti tega zdravila.
English: The recommended dose is 50 mg taken as needed approximately one hour before sexual activity.
Slovenian: Priporočeni odmerek je 50 mg, uporabljen kot je potrebno, približno eno uro pred spolno dejavnostjo.
English: In order to get the maximum benefit from your medicine, it is recommended that you avoid alcohol before intake of this medicine.
Slovenian: Za najboljši učinek tega zdravila se priporoča, da pred jemanjem tega zdravila ne pijete alkohola.
English: Cardiovascular risk factors
Slovenian: Kardiovaskularni dejavniki tveganja
English: In addition, physicians should advise patients what to do in the event of postural hypotensive symptoms.
Slovenian: Poleg tega morajo zdravniki bolnikom svetovati, kaj naj storijo v primeru simptomov posturalne hipotenzije.
English: It is not possible to determine whether these events were directly related to Sildenafil ratiopharm.
Slovenian: Ni mogoče določiti, ali so ti dogodki neposredno povezani z zdravilom Sildenafil ratiopharm.
English: In this case, he/she may decide to give you a lower dose.
Slovenian: Morda se bo odločil, da vam predpiše manjši odmerek.
English: Effect on bleeding
Slovenian: Vpliv na krvavitve
English: Many events were reported to occur during or shortly after sexual intercourse and a few were reported to occur shortly after the use of sildenafil without sexual activity.
Slovenian: Za številne dogodke je bilo opisano, da so se zgodili med ali kmalu po spolnem odnosu, nekateri pa so se pojavili kmalu po uporabi sildenafila, brez spolne dejavnosti.
English: In order for sildenafil to be effective, sexual stimulation is required.
Slovenian: Da bi bil sildenafil učinkovit, je potrebna spolna stimulacija.
English: Very common (may affect more than 1 in 10 people): headache.
Slovenian: Zelo pogosti (pojavi se lahko pri več kot 1 od 10 bolnikov): glavobol.
English: Use in patients taking other medicinal products
Slovenian: Uporaba pri bolnikih, ki jemljejo druga zdravila
English: In clinical trials sildenafil was administered to more than 8,000 patients aged 19-87.
Slovenian: V kliničnih preskušanjih je sildenafil dobivalo več kot 8000 bolnikov, starih od 19 do 87 let.
English: It reduces the action of the natural chemical in your body, which makes erections go away.
Slovenian: Zmanjša delovanje naravne kemične snovi v telesu, ki ustavi erekcijo.
English: The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.
Slovenian: V natisnjenem navodilu za uporabo zdravila mora biti navedena ime in naslov izdelovalca, odgovornega za sprostitev zadevne serije.
English: Further information on clinical trials
Slovenian: Dodatne informacije o kliničnih študijah
English: You should not take more film-coated tablets than your doctor tells you to.
Slovenian: Ne vzemite več filmsko obloženih tablet, kot vam je predpisal zdravnik.
English: The amount of time Sildenafil ratiopharm takes to work varies from person to person, but it normally takes between half an hour and one hour.
Slovenian: Čas, potreben za začetek delovanja zdravila Sildenafil ratiopharm, se od posameznika do posameznika razlikuje, a ponavadi traja od pol ure do eno uro.
English: - Prolonged and sometimes painful erections - this occurs rarely (may affect up to 1 in 1,000 people).
Slovenian: Podaljšana in včasih boleča erekcija - to se zgodi redko (pojavi se lahko pri največ 1 od 1.000 bolnikov).
English: Mean pulmonary systolic blood pressure decreased by 9%.
Slovenian: Srednji pljučni sistolični krvni tlak se je zmanjšal za 9 %.
English: Do not use nitrates to treat your chest pain.
Slovenian: • Ne vzemite nitratov, ki jih uporabljate za bolečine v prsnem košu.
English: This medicine will only help you to get an erection if you are sexually stimulated.
Slovenian: To zdravilo vam bo pomagalo doseči erekcijo samo, če ste spolno stimulirani.
English: The mean absolute oral bioavailability is 41% (range 25-63%).
Slovenian: Srednja absolutna peroralna biološka uporabnost je 41 % (razpon: od 25 do 63 %).
English: Swallow the film-coated tablet whole with a glass of water.
Slovenian: Filmsko obloženo tableto pogoltnite celo s kozarcem vode.
English: These reports included dizziness and light-headedness, but not syncope.
Slovenian: Ta poročila so obsegala omotico in rahlo vrtoglavico, ne pa sinkope.
English: If you are taking one of these medicines, your doctor may start you on the lowest dose (25 mg) of Sildenafil ratiopharm.
Slovenian: Če jemljete katero koli od teh zdravil, vam bo morda zdravnik na začetku predpisal najmanjši odmerek (25 mg) zdravila Sildenafil ratiopharm.
English: If this medicine does not help you to get an erection, or if your erection does not last long enough for you to complete sexual intercourse, you should tell your doctor.
Slovenian: Če vam to zdravilo ne pomaga doseči erekcije ali dosežena erekcija ne traja dovolj dolgo za popoln spolni odnos, morate to povedati zdravniku.
English: Due to the nitrate component it has the potential to result in a serious interaction with sildenafil.
Slovenian: Zaradi nitratne sestavine je možno, da povzroči resno medsebojno učinkovanje s sildenafilom.
English: - if you have a severe heart problem.
Slovenian: če imate težave s srcem.
English: The safety profile of sildenafil is based on 9,570 patients in 74 double-blind placebo-controlled clinical studies.
Slovenian: Varnostni profil sildenafila temelji na 9.570 bolnikih v 74 dvojno slepih, s placebom nadzorovanih kliničnih študijah.
English: Because not all adverse reactions are reported to the Marketing Authorisation Holder and included in the safety database, the frequencies of these reactions cannot be reliably determined.
Slovenian: Ker imetniku dovoljenja za promet z zdravilom ne poročajo o vseh neželenih učinkih in le-ti niso zajeti v podatkovni bazi o varnosti, pogostnosti neželenih učinkov ne moremo zanesljivo določiti.
English: You should not take Sildenafil ratiopharm more than once a day.
Slovenian: Zdravila Sildenafil ratiopharm ne vzemite več kot enkrat na dan.